Table of contents
Volume 94, Issue 11
Published online 30 May 2006 (1555-1763)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor |
Book Review
Minireviews
ARF-BP1 as a potential therapeutic target FREE
D Chen, C L Brooks and W Gu
Br J Cancer 94: 1555-1558; advance online publication, April 25, 2006; doi:10.1038/sj.bjc.6603119
Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review FREE
R F Bell, T Wisløff, C Eccleston and E Kalso
Br J Cancer 94: 1559-1567; advance online publication, May 16, 2006; doi:10.1038/sj.bjc.6603162
Clinical Studies
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer FREE
A B C Crumley, D C McMillan, M McKernan, J J Going, C J Shearer and R C Stuart
Br J Cancer 94: 1568-1571; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603150
A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma FREE
A Eickhoff, W Martin, D Hartmann, J C Eickhoff, M Möhler, P R Galle, J F Riemann and R Jakobs
Br J Cancer 94: 1572-1574; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603174
Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer FREE
K Nakamura, T Yamaguchi, T Ishihara, K Sudo, H Kato and H Saisho
Br J Cancer 94: 1575-1579; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603168
Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx FREE
S Takagi, R Inenaga, R Oya, S Nakamura and K Ikemura
Br J Cancer 94: 1580-1585; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603138
Clinical outcome and risk factors for recurrence in borderline ovarian tumours FREE
Y Yokoyama, T Moriya, T Takano, T Shoji, O Takahashi, K Nakahara, H Yamada, N Yaegashi, K Okamura, T Izutsu, T Sugiyama, T Tanaka, H Kurachi, A Sato, T Tase and H Mizunuma
Br J Cancer 94: 1586-1591; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603139
Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles FREE
G Kramer, S Schwarz, M Hägg, A Mandic Havelka and S Linder
Br J Cancer 94: 1592-1598; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603129
A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer FREE
R Suzuki, Y Hasegawa, K Baba, H Saka, H Saito, H Taniguchi, M Yamamoto, S Matsumoto, K Kato, T Oishi, K Imaizumi and K Shimokata on behalf of the Central Japan Lung Study Group
Br J Cancer 94: 1599-1603; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603159
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer FREE
F Ciardiello, T Troiani, F Caputo, M De Laurentiis, G Tortora, G Palmieri, F De Vita, M R Diadema, M Orditura, G Colantuoni, C Gridelli, G Catalano, S De Placido and A R Bianco
Br J Cancer 94: 1604-1609; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603141
A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer FREE
L Zelek, A Yovine, E Brain, F Turpin, A Taamma, M Riofrio, M Spielmann, J Jimeno and J L Misset
Br J Cancer 94: 1610-1614; doi:10.1038/sj.bjc.6603142
The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial FREE
S-E Al-Batran, J Bischoff, G von Minckwitz, A Atmaca, U Kleeberg, I Meuthen, G Morack, W Lerbs, D Hecker, J Sehouli, A Knuth and E Jager
Br J Cancer 94: 1615-1620; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603158
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours FREE
M E Cianfrocca, K A Kimmel, J Gallo, T Cardoso, M M Brown, G Hudes, N Lewis, L Weiner, G N Lam, S C Brown, D E Shaw, A P Mazar and R B Cohen
Br J Cancer 94: 1621-1626; advance online publication, May 16, 2006; doi:10.1038/sj.bjc.6603171
Translational Therapeutics
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells FREE
D Fontijn, M C A Duyndam, M P A van Berkel, Y Yuana, L H Shapiro, H M Pinedo, H J Broxterman and E Boven
Br J Cancer 94: 1627-1636; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603157
Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086 FREE
C Cellai, A Laurenzana, A M Vannucchi, R Caporale, M Paglierani, S Di Lollo, A Pancrazzi and F Paoletti
Br J Cancer 94: 1637-1642; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603156
Molecular Diagnostics
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study FREE
G G Van den Eynden, I Van der Auwera, S J Van Laere, C G Colpaert, P van Dam, L Y Dirix, P B Vermeulen and E A Van Marck
Br J Cancer 94: 1643-1649; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603152
Role of lymphangiogenesis in epithelial ovarian cancer FREE
S S Sundar, H Zhang, P Brown, S Manek, C Han, K Kaur, M F L Charnock, D Jackson and T S Ganesan
Br J Cancer 94: 1650-1657; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603144
Nucleostemin mRNA is expressed in both normal and malignant renal tissues FREE
Y Fan, Z Liu, S Zhao, F Lou, S Nilsson, P Ekman, D Xu and X Fang
Br J Cancer 94: 1658-1662; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603145
Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues FREE
A G Lowrie, S J Wigmore, D J Wright, I D Waddell and J A Ross
Br J Cancer 94: 1663-1671; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603148
Securin (hPTTG1) expression is regulated by 
-catenin/TCF in human colorectal carcinoma FREE
F Hlubek, S Pfeiffer, J Budczies, S Spaderna, A Jung, T Kirchner and T Brabletz
Br J Cancer 94: 1672-1677; advance online publication, May 16, 2006; doi:10.1038/sj.bjc.6603155
Increased expression of pAKT is associated with radiation resistance in cervical cancer FREE
T-J Kim, J-W Lee, S Y Song, J-J Choi, C H Choi, B-G Kim, J-H Lee and D-S Bae
Br J Cancer 94: 1678-1682; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603180
Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer FREE
C Beskow, L Kanter, Å Holgersson, B Nilsson, B Frankendal, E Åvall-Lundqvist and R Lewensohn
Br J Cancer 94: 1683-1689; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603153
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle FREE
M E Sherman, J D Carreon and M Schiffman for the ALTS Group
Br J Cancer 94: 1690-1696; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603151
Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides FREE
K Aaltonen, C Ahlin, R-M Amini, L Salonen, M-L Fjällskog, P Heikkilä, H Nevanlinna and C Blomqvist
Br J Cancer 94: 1697-1702; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603147
The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients FREE
A A Memon, B S Sorensen, P Meldgaard, L Fokdal, T Thykjaer and E Nexo
Br J Cancer 94: 1703-1709; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603154
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases FREE
D P Lesslie III, J M Summy, N U Parikh, F Fan, J G Trevino, T K Sawyer, C A Metcalf III, W C Shakespeare, D J Hicklin, L M Ellis and G E Gallick
Br J Cancer 94: 1710-1717; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603143
Prostaglandin E2 stimulates progression-related gene expression in early colorectal adenoma cells FREE
I Mauritz, S Westermayer, B Marian, N Erlach, M Grusch and K Holzmann
Br J Cancer 94: 1718-1725; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603146
Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control FREE
A Seidel, S Brunner, P Seidel, G I Fritz and O Herbarth
Br J Cancer 94: 1726-1733; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603164
Epidemiology
Birth weight and breast cancer risk FREE
R Troisi, E E Hatch, L Titus-Ernstoff, J R Palmer, M Hyer, W C Strohsnitter, S J Robboy, R Kaufman, A Herbst, E Adam and R N Hoover
Br J Cancer 94: 1734-1737; advance online publication, April 25, 2006; doi:10.1038/sj.bjc.6603122
Birth weight, maternal weight and childhood leukaemia FREE
C C McLaughlin, M S Baptiste, M J Schymura, P C Nasca and M S Zdeb
Br J Cancer 94: 1738-1744; doi:10.1038/sj.bjc.6603173
Multiple primary tumours in women following breast cancer, 1973–2000 FREE
J S Raymond and C J R Hogue
Br J Cancer 94: 1745-1750; advance online publication, May 23, 2006; doi:10.1038/sj.bjc.6603172
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001 FREE
J West, H Wood, R F A Logan, M Quinn and G P Aithal
Br J Cancer 94: 1751-1758; doi:10.1038/sj.bjc.6603127
Letters to the Editor
Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data FREE
A Czarnecki and S Voss
Br J Cancer 94: 1759-1760; advance online publication, May 9, 2006; doi:10.1038/sj.bjc.6603161
The relevance of RT–PCR markers for metastatic tumour cell detection FREE
M Chechli
ska, M Kowalewska, S Markowicz and R Nowak
Br J Cancer 94: 1761; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603131
Reply: Specificity of RT–PCR for the detection of minimal residual disease in breast cancer patients FREE
A Nissan and S Mitrani-Rosenbaum
Br J Cancer 94: 1762; advance online publication, May 2, 2006; doi:10.1038/sj.bjc.6603130
Book Review
IASLC Textbook of Prevention and Early Detection of Lung Cancer FREE
S G Spiro
Br J Cancer 94: 1763; advance online publication, May 3, 2006; doi:10.1038/sj.bjc.6603136
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
